This type of HCC is characterized by the lack of CTNNB1 mutations, global hypermethylation, expression of PD-1 and PD-L1 in tumor infiltrating lymphocytes (TILs), and expression of PD-L1 in tumors. This evidence concerns the gene CD274 and hepatocellular carcinoma.